PRA Health Sciences

Side-by-side with our clients, we strive to move drug discovery forward, helping them to develop life-saving and life-improving drugs. PRA has more than 12,000 employees working in 80+ countries providing comprehensive clinical development services across all phases. From full service clinical development to the pioneering Embedded Solutions™ model, PRA provides a broad spectrum of solutions that meet the demands of a diverse marketplace. As a top five CRO, we have worked on 100+ marketed drugs across several therapeutic areas and conducted the pivotal or supportive trials that led to FDA and/or international regulatory approval of 50+ such drugs.

Raleigh, US
Size (employees)
13,000 (est)+9%
PRA Health Sciences was founded in 1976 and is headquartered in Raleigh, US

PRA Health Sciences Office Locations

PRA Health Sciences has an office in Raleigh
Raleigh, US (HQ)
400 4130 Parklake Ave

PRA Health Sciences Data and Metrics

PRA Health Sciences Financial Metrics

PRA Health Sciences's revenue was reported to be $1.8 b in FY, 2016 which is a 12% increase from the previous period.

Revenue (FY, 2016)

1.8 b

Revenue growth (FY, 2015 - FY, 2016), %


Net income (FY, 2016)

68.2 m

EBIT (FY, 2016)

162.3 m

Market capitalization (28-Jun-2017)

4.7 b

Closing share price (28-Jun-2017)


Cash (31-Dec-2016)

144.6 m
PRA Health Sciences's current market capitalization is $4.7 b.
USDFY, 2015FY, 2016


1.6 b1.8 b

Revenue growth, %


General and administrative expense

69.7 m269.9 m

Operating expense total

69.7 m269.9 m


(22.7 m)162.3 m

EBIT margin, %


Interest expense

(23.7 m)(54.9 m)

Income tax expense

(17.2 m)28.5 m

Net Income

(39.9 m)68.2 m
USDFY, 2015FY, 2016


121.1 m144.6 m


30.2 m35.4 m

Current Assets

573.8 m624.7 m


1 b972 m

Total Assets

2.2 b2.2 b

Accounts Payable

57.1 m51.3 m

Current Liabilities

530 m564.2 m

Additional Paid-in Capital

828.3 m879.1 m

Retained Earnings

6.1 m74.3 m

Total Equity

702.7 m729.3 m

Financial Leverage

3.2 x3 x
USDFY, 2015FY, 2016

Net Income

(39.9 m)68.2 m

Depreciation and Amortization

25.3 m69.5 m

Accounts Payable

(46.2 m)(1.5 m)

Cash From Operating Activities

35.9 m160 m

Purchases of PP&E

(4.9 m)(33.1 m)

Cash From Investing Activities

(1 b)(34.6 m)

Long-term Borrowings

(567.1 m)(822.6 m)

Cash From Financing Activities

1.1 b(101.6 m)

Income Taxes Paid

3.1 m7.3 m
USDY, 2016


151 k

Financial Leverage

3 x

PRA Health Sciences Market Value History

PRA Health Sciences Revenue Breakdown

PRA Health Sciences Online and Social Media Presence

PRA Health Sciences News and Updates

PRA Health Sciences Company Life and Culture

You may also be interested in